| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/07/2007 | CN1907277A Use of short-leave geranium component in preparation of tumor growth and proliferation inhibitor |
| 02/07/2007 | CN1907276A Application of hydroxybenzoate acid and its analogue in the preparing process of medicine for preventing and treating virus infection |
| 02/07/2007 | CN1298856C Technique for improving activity of Job's-tears seed |
| 02/07/2007 | CN1298851C Polypeptide |
| 02/07/2007 | CN1298743C Fusion protein, gene encoding same, and use thereof |
| 02/07/2007 | CN1298731C Antineoplastic compound, its preparation method and medicine composition with compound as active ingredient |
| 02/07/2007 | CN1298727C Novel liposoluble platinum (II) anti-tumor ligand |
| 02/07/2007 | CN1298722C Indole carbazole alkaloid and its preparing method and use |
| 02/07/2007 | CN1298719C Purine derivatives, preparation method and pharmaceutical compositions containing same |
| 02/07/2007 | CN1298718C Derivative of sinomenine with pyrazinc cyclc being connected to C cycle, synthetic method and application |
| 02/07/2007 | CN1298709C Thiophene-and thiazolesulfonamides as antineoplastic agents |
| 02/07/2007 | CN1298707C Imidazole and benzimiddzole caspase inhibitors and uses thereof |
| 02/07/2007 | CN1298703C Cyanopyrolidine derivatives |
| 02/07/2007 | CN1298385C Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof |
| 02/07/2007 | CN1298379C Medicine for curing malignant tumors of carcinoma of prostate, liver cancer and sarcoma |
| 02/07/2007 | CN1298373C Chinese medicine for treating hypertension |
| 02/07/2007 | CN1298359C Chinese patent medicine for treating esophagus cancer |
| 02/07/2007 | CN1298332C Medicine composition comprising arsenite for treatment of malignancy |
| 02/07/2007 | CN1298329C Use of lycopene in producing medicine |
| 02/07/2007 | CN1298328C Combination therapy comprising ZD6474 and a taxane |
| 02/07/2007 | CN1298327C Leurocristine sulfate liposome compositions, and its prepn. method |
| 02/07/2007 | CN1298325C Stabilized oil-in-water emulsion of matrine alkaloid for venous purpose and production thereof |
| 02/07/2007 | CN1298324C Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (PDE4) inhibitors |
| 02/07/2007 | CN1298323C Fused pyrrolocarbazoles against inflammation |
| 02/07/2007 | CN1298319C Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and lower animals |
| 02/07/2007 | CN1298314C Stable salts of O-acetylsalicylic acid containing basic amino acids II |
| 02/06/2007 | US7173136 3-Cyano-quinoline derivatives |
| 02/06/2007 | US7173134 retinoid X receptors ("RXRs"); useful for the treatment of diabetes (NIDDIM) and obesity; for example, 3-{4-[(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydro-2-naphthalenyl)methyl]-2-furyl}-2-propenoic acid |
| 02/06/2007 | US7173115 Nucleotide sequences coding polypeptides for use in the diagnosis and treatment of cancer |
| 02/06/2007 | US7173060 Antitumor agents, anticarcinogenic agents; inhibitors of histone deacetylase; a methyleneaminooxymethyl)-thiophene-2-carboxylic acid (2-amino-phenyl)-amide derivatives; chemical synthesis |
| 02/06/2007 | US7173047 Benzo (f) insoindol derivatives and their use as ep4 receptor ligands |
| 02/06/2007 | US7173043 Heteroaromate OSC inhibitors |
| 02/06/2007 | US7173040 4-phenyl-6-alpha-(imidazolyl-, 1,2,4-triazolyl- or pyridyl)-benzyl substituted |
| 02/06/2007 | US7173038 Treatment of diseases such as cancer or arthritis |
| 02/06/2007 | US7173036 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 02/06/2007 | US7173032 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 02/06/2007 | US7173031 Pyrrolotriazine kinase inhibitors |
| 02/06/2007 | US7173028 Pyrimidine derivatives |
| 02/06/2007 | US7173027 Provide a physiological effect to a subject |
| 02/06/2007 | US7173026 Pyrrolo [2,1-c][1,4]benzodiazepine-anthraquinone conjugates useful as antitumour agents |
| 02/06/2007 | US7173021 Anticancer agents, prodrugs for treatment on skins and basification |
| 02/06/2007 | US7173020 Anticancer agents and drug delivery agents with nucleotides |
| 02/06/2007 | US7173008 Lyophilized HGF preparations |
| 02/06/2007 | US7173006 Drug comprising synthetic peptide analogs for the treatment of cancer |
| 02/06/2007 | US7172893 Virus vectors and methods of making and administering the same |
| 02/06/2007 | US7172892 Exhibit protease activity as a single chain or as an activated two chain form; use of polypeptides to identify compounds that modulate the protease activity thereof and as tumor markers |
| 02/06/2007 | US7172769 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 02/06/2007 | US7172759 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 02/06/2007 | US7172749 Radiolabeled irreversible inhibitors of epidermal growth factor receptor tyrosine kinase and their use in radioimaging and radiotherapy |
| 02/06/2007 | CA2385755C Prevention of colorectal cancer |
| 02/06/2007 | CA2287262C Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
| 02/06/2007 | CA2286903C Pharmaceutical compositions for immunosuppression, anticancer and antiviral treatment |
| 02/06/2007 | CA2238884C Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
| 02/06/2007 | CA2214320C Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 02/06/2007 | CA2090967C Water soluble camptothecin analogues, processes and methods |
| 02/03/2007 | CA2555410A1 Compositions and methods for enhancing immunity by chemoattractant adjuvants |
| 02/01/2007 | WO2007014335A2 Combinations comprising gemcitabine and tyrosine kinase inhibitors for the treatment of pancreatic cancer |
| 02/01/2007 | WO2007014198A1 1, 2, 3 -triazoles inhibitors of tubulin polymerization for the treatment of poliferative disorders |
| 02/01/2007 | WO2007013964A1 Pyrazolo pyrimidines useful as aurora kinase inhibitors |
| 02/01/2007 | WO2007013824A1 Biologically active extracts from stephania brachyandra |
| 02/01/2007 | WO2007013793A1 Sensitization of immune system against haptenized melanoma antigens |
| 02/01/2007 | WO2007013696A1 Anti-tumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 02/01/2007 | WO2007013627A1 Therapeutic agent for b-lymphoma and hodgkin lymphoma |
| 02/01/2007 | WO2007013600A1 Neutron capture preparation and use thereof |
| 02/01/2007 | WO2007013593A1 Method for diagnosis of gastric cancer utilizing methylation of novel gene acmg1 as index |
| 02/01/2007 | WO2007013588A1 Strain of turkey tail mushroom, extract from the same, and use of the same |
| 02/01/2007 | WO2007013574A1 Compositions and methods for treating breast cancer |
| 02/01/2007 | WO2007013556A1 Composition for prevention of cancer |
| 02/01/2007 | WO2007013490A1 Aqueous solution preparation containing camptothecins |
| 02/01/2007 | WO2007013480A2 Screening and therapeutic method for nsclc targeting cdca1-kntc2 complex |
| 02/01/2007 | WO2007013411A1 Anti-sense nucleic acid derived from organism |
| 02/01/2007 | WO2007013352A1 Medicinal composition containing hla-a24 molecule-binding peptide originating in parathyroid hormone-related protein |
| 02/01/2007 | WO2007013147A1 Angiogenesis inhibitor and vascular regressive agent |
| 02/01/2007 | WO2007012876A1 Hydrogel particle |
| 02/01/2007 | WO2007012811A2 Prostate stem cell markers |
| 02/01/2007 | WO2007012335A1 Treatment for all types of cancer, cysts, fibromas, infections, inflammations, anxiety, migraines, hormonal imbalance, ulcers, asthma, crohn's disease, eczema, psoriasis, rheumatism, acne |
| 02/01/2007 | WO2007012183A1 Process for the production of bicalutamide |
| 02/01/2007 | WO2007012133A1 Therapeutic protocols using hyaluronan |
| 02/01/2007 | WO2006133654B1 USE OF NF-κB INHIBITOR FOR TREATING SEVERAL DISEASES |
| 02/01/2007 | WO2006131496A3 Hdac regulation assays, compounds and therapeutic compositions |
| 02/01/2007 | WO2006097744A3 Phenol derivatives and their use to modulate pkb activity |
| 02/01/2007 | WO2006091326A8 Anti-prl-3 antibodies and methods of use thereof |
| 02/01/2007 | WO2006012644A3 Use of il-28 and il-29 to treat cancer |
| 02/01/2007 | WO2006007398A9 Therapy of platinum-resistant cancer |
| 02/01/2007 | WO2005112919A3 Self-immolative linkers and drug conjugates |
| 02/01/2007 | WO2004003005A3 Sh2 domain binding inhibitors |
| 02/01/2007 | US20070027318 Quinoline derivatives and quinazoline derivatives |
| 02/01/2007 | US20070027200 Bis-benzimidazoles and related compounds as potassium channel modulators |
| 02/01/2007 | US20070027196 Activator of peroxisome proliferator-activated receptor delta |
| 02/01/2007 | US20070027189 Use of known active ingredients as radical scavengers |
| 02/01/2007 | US20070027167 Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemia |
| 02/01/2007 | US20070027157 Quinoxalinone-3-one derivatives as orexin receptor antagonists |
| 02/01/2007 | US20070027149 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone der derivatives as protein kinase inhibitors |
| 02/01/2007 | US20070027147 Biarylurea derivatives |
| 02/01/2007 | US20070027124 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070027123 Administering an estrogen receptor for treatment of osteoporosis, breast cancer, hypercholesteremia, hyperlipidemia or artheriosclerosis by administering estrogen modulators |
| 02/01/2007 | US20070027122 Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026457 Screening method |
| 02/01/2007 | US20070026450 Methods for the treatment of carcinoma |